S Kang1, S Luk2, H Han2, M F Cordeiro2,3,4, F Ahmed2,3, P Bloom2,3, L Crawley2,3. 1. Imperial College Healthcare NHS Trust, The Western Eye Hospital, 153-173 Marylebone Road, London, NW1 5QH, UK. swan_kang@hotmail.com. 2. Imperial College Healthcare NHS Trust, The Western Eye Hospital, 153-173 Marylebone Road, London, NW1 5QH, UK. 3. Imperial College London, London, UK. 4. Glaucoma and Retinal Neuro-degeneration Research Group, UCL Institute of Ophthalmology, London, UK.
Abstract
PURPOSE: To compare the refractive outcome of eyes that underwent phacoemulsification combined with endoscopic cyclophotocoagulation (phaco-ECP) with the eyes that underwent phacoemulsification alone. METHODS: A retrospective case series review of 103 consecutive eyes that underwent phaco-ECP and 62 eyes that underwent phacoemulsification between January 2006 and August 2012 was conducted. Post-operative refractive outcomes were obtained by subjective refraction or autorefraction. Demographic data, best corrected visual acuity, intraocular pressure, number of glaucoma agents and mean deviation of the Humphrey visual field test (MD) were also analysed. RESULTS: The total number of eyes included in the study was 62 eyes for the phaco-ECP group and 62 eyes for the control group who underwent phacoemulsification alone. More than 90% of eyes (n = 56) in phaco-ECP group achieved post-operative refraction within ±1 dioptre (D) of the target refraction. In the control group, 100% of eyes achieved post-operative refraction within ±1D of the target refraction. When comparing the difference between the target and the actual refractive outcome between the phaco-ECP and the control group, there was no statistically significant difference. CONCLUSIONS: Refractive outcome after phaco-ECP is comparable to phacoemulsification alone. This study suggests that the intraocular lens power can be selected for cataract surgery alone and that ECP does not change the effective lens position significantly; therefore, no modification of biometry formulae is required. Phaco-ECP should be considered as an effective, safe and predictable surgical treatment option for glaucoma patients with co-existing cataract.
PURPOSE: To compare the refractive outcome of eyes that underwent phacoemulsification combined with endoscopic cyclophotocoagulation (phaco-ECP) with the eyes that underwent phacoemulsification alone. METHODS: A retrospective case series review of 103 consecutive eyes that underwent phaco-ECP and 62 eyes that underwent phacoemulsification between January 2006 and August 2012 was conducted. Post-operative refractive outcomes were obtained by subjective refraction or autorefraction. Demographic data, best corrected visual acuity, intraocular pressure, number of glaucoma agents and mean deviation of the Humphrey visual field test (MD) were also analysed. RESULTS: The total number of eyes included in the study was 62 eyes for the phaco-ECP group and 62 eyes for the control group who underwent phacoemulsification alone. More than 90% of eyes (n = 56) in phaco-ECP group achieved post-operative refraction within ±1 dioptre (D) of the target refraction. In the control group, 100% of eyes achieved post-operative refraction within ±1D of the target refraction. When comparing the difference between the target and the actual refractive outcome between the phaco-ECP and the control group, there was no statistically significant difference. CONCLUSIONS: Refractive outcome after phaco-ECP is comparable to phacoemulsification alone. This study suggests that the intraocular lens power can be selected for cataract surgery alone and that ECP does not change the effective lens position significantly; therefore, no modification of biometry formulae is required. Phaco-ECP should be considered as an effective, safe and predictable surgical treatment option for glaucomapatients with co-existing cataract.
Authors: Petros Aristodemou; Nathaniel E Knox Cartwright; John M Sparrow; Robert L Johnston Journal: J Cataract Refract Surg Date: 2011-01 Impact factor: 3.351
Authors: Colin I Clement; George Kampougeris; Faisal Ahmed; M Francesca Cordeiro; Philip A Bloom Journal: Clin Exp Ophthalmol Date: 2013-01-24 Impact factor: 4.207
Authors: Victoria de Juan; José María Herreras; Inmaculada Pérez; Ángela Morejón; Ana Río-Cristóbal; Ana Río-San Cristóbal; Raúl Martín; Itziar Fernández; Guadalupe Rodríguez Journal: Optom Vis Sci Date: 2013-01 Impact factor: 1.973
Authors: David C Musch; Brenda W Gillespie; Leslie M Niziol; Nancy K Janz; Patricia A Wren; Edward J Rockwood; Paul R Lichter Journal: Arch Ophthalmol Date: 2006-12
Authors: Ana Marta; João Coelho; Rita Vieira; Ana Figueiredo; Rita Reis; Isabel Sampaio; Maria João Menéres; Pedro Menéres Journal: Clin Ophthalmol Date: 2021-05-14
Authors: Erin G Sieck; Cara E Capitena Young; Rebecca S Epstein; Jeffrey R SooHoo; Mina B Pantcheva; Jennifer L Patnaik; Anne M Lynch; Malik Y Kahook; Leonard K Seibold Journal: Eye Vis (Lond) Date: 2019-09-19